Interaction between increased SERCA2a activity and β-adrenoceptor stimulation in adult rabbit myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 6 52-6, 2002, Pages

  Chaudhri, Babar ^a   Del Monte, Federica ^b   Hajjar, Roger J ^a   Harding, Sian E ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Aftercontraction; Antisense; Arrhythmia; Phospholamban

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOVIRUS VECTOR; CALCIUM ION; PHOSPHOLAMBAN;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE TRANSFER; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SARCOPLASMIC RETICULUM; SYMPATHETIC TONE;

EID: 0036889541     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00391.2002     Document Type: Article

References (36)

1. 2+-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res 83: 1205-1214, 1998.
2. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 87: 275-281, 2000.
3. Bers DM. Calcium and cardiac rhythms: Physiological and pathophysiological. Circ Res 90: 14-17, 2002.
4. Davia K, Bernobich E, Ranu HK, del Monte F, Terracciano CMN, MacLeod KT, Adamson DL, Chaudhri B, Hajjar RJ, and Harding SE. SERCA2a overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes. J Mol Cell Cardiol 33: 1005-1015, 2001.
5. Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, and Harding SE. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92: 2540-2549, 1995.
6. Del Monte F, Harding SE, Dec GW, Gwathmey JK, and Hajjar RJ. Targeting phospholamban in human heart failure by gene transfer. Circulation 105: 904-907, 2002.
7. Del Monte F, Harding SE, and Hajjar RJ. Manipulation of SERCA2a in the heart by gene transfer. In: Molecular Approaches to the Therapy of Heart Failure, edited by Hasenfus G and Marban E. Heidelberg, Germany: Steinkopff-Verlag, 2002, p. 53-68.
8. Del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW, Gwathmey JK, Rosenzweig A, and Hajjar RJ. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100: 2308-2311, 1999.
9. Del Monte F, O'Gara P, Poole-Wilson PA, Yacoub MH, and Harding SE. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res 30: 281-290, 1995.
10. 2+-ATPase in a rat model of heart failure. Circulation 104: 1424-1429, 2001.
11. Freeman K, Lerman I, Kranias EG, Bohlmeyer T, Bristow MR, Lefkowitz RJ, Iaccarino G, Koch WJ, and Leinwand LA. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest 107: 967-974, 2001.
12. Harding SE, Brown LA, del Monte F, Davies CH, O'Gara P, Vescovo G, Wynne DG, and Poole-Wilson PA. Acceleration of contraction by β-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Res Cardiol 91, Suppl 2: 53-56, 1996.
13. 2+-ATPase activity and cardiac myocyte contractility. Circulation 100: 974-980, 1999.
14. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514, 1998.
15. 2+ ATPase modifies the transition from hypertrophy to early heart failure. Circ Res 89: 422-429, 2001.
16. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, and Solaro RJ. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 88: 1059-1065, 2001.
17. Kranias EG and Solaro RJ. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature 298: 182-184, 1982.
18. Li L, Desantiago J, Chu G, Kranias EG, and Bers DM. Phosphorylation of phospholamban and troponin I in β-adrenergic-induced acceleration of cardiac relaxation. Am J Physiol Heart Circ Physiol 278: H769-H779, 2000.
19. Li Q, Biagi B, Starling R, Stokes B, and Altschuld RA. Effects of isoproterenol and caffeine on calcium transients and action potentials in human ventricular muscle. Prog Clin Biol Res 327: 743-750, 1990.
20. Luo W, Grupp IL, Ponniah S, Grupp G, Duffy JJ, Doetschman T, and Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75: 401-409, 1994.
21. Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross JJ, Kranias EG, Giles WR, and Chien KR. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99: 313-322, 1999.
22. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, and Hajjar RJ. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 97: 793-798, 2000.
23. Pan BS, Hannon JD, Wiedmann R, Potter JD, Kranias EG, Shen YT, Johnson RGJ, and Housmans PR. Effects of isoproterenol on twitch contraction of wild type and phospholamban-deficient murine ventricular myocardium. J Mol Cell Cardiol 31: 159-166, 1999.
24. Pi Y, Kemnitz KR, Zhang D, Kranias EG, and Walker JW. Phosphorylation of troponin I controls cardiac twitch dynamics: Evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ Res 90: 649-656, 2002.
25. Priori SG, Napolitano R, and Schwartz PJ. Electrophysiologic mechanisms involved in the development of torsades de pointes. Cardiovasc Drugs Ther 5, 203-212, 1991.
26. 2+-ATPase. Circulation 101: 790-796, 2000.
27. 2+ channels. Am J Physiol Heart Circ Physiol 276: H834-H843, 1999.
28. i restores uncoupled β-adrenergic signaling in isolated perfused transgenic mouse hearts. Circ Res 88: 9-11, 1988.
29. Slack JP, Grupp IL, Dash R, Holder D, Schmidt A, Gerst MJ, Tamura T, Tilgmann C, James PF, Johnson R, Gerdes AM, and Kranias EG. The enhanced contractility of the phospholamban-deficient mouse heart persists with aging. J Mol Cell Cardiol 33: 1031-1040, 2001.
30. Terracciano CM, Naqvi RU, and MacLeod KT. Effects of rest interval on the release of calcium from the sarcoplasmic reticulum in isolated guinea-pig ventricular myocytes. Circ Res 77: 354-360, 1995.
31. 2+-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002.
32. Tsien RW, Bean BP, Hess P, Lansman JB, Nilius B, and Nowycky MC. Mechanisms of calcium channel modulation by β-adrenergic agents and dihydropyridine calcium agonists. J Mol Cell Cardiol 18: 691-710, 1986.
33. Tweedie D, O'Gara P, Harding SE, and MacLeod KT. The effect of alterations to action potential duration on β-adrenoceptor-mediated aftercontractions in human and guinea-pig ventricular myocytes. J Mol Cell Cardiol 29: 1457-1467, 1997.
34. Wolska BM, Arteaga GM, Pena JR, Nowak G, Phillips RM, Sahai S, de Tombe PP, Martin AF, Kranias EG, and Solaro RJ. Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of β-adrenergic stimulation. Circ Res 90: 882-888, 2002.
35. 2+. Am J Physiol Cell Physiol 271: C391-C397, 1996.
36. Zeng LH and Rudy Y. Early afterdepolarisations in cardiac myocytes: Mechanism and rate dependence. Biophys J 68: 949-964, 1995.